PFM Health Sciences’s Cardinal Health CAH Stock Holding History

PFM Health Sciences’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-500,000	Closed	-$26.1M	–	78
2020 Q2	$26.1M	Buy	+500,000	New	+$25.8M	1.35%	31

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

PFM Health Sciences's CAH Position: Q2 2026 in Review

PFM Health Sciences sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 31,941 shares — an estimated $6.75M sold.

PFM Health Sciences first reported a position in CAH in Q3 2014 and held it in 14 quarters. The position peaked at $60.5M in Q2 2023. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

PFM Health Sciences reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
PFM Health Sciences sold 31,941 Cardinal Health shares in Q2 2026, an estimated $6.75M.
PFM Health Sciences first reported a position in Cardinal Health in Q3 2014 and held it in 14 quarters.
PFM Health Sciences's Cardinal Health position peaked at $60.5M in Q2 2023.
1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.